Pennant Group (PNTG) - Price-to-Projected Revenue Ratio

Public company logo of pennantgroup.com (PNTG)

The Pennant Group, Inc. (PNTG) management acts as an active serial consolidator, acquiring local agencies to accelerate growth. The expected revenue multiple visualizes the results of this expansion, where the indicator value is 0.70. The strategy is based on consolidating hospices and care services against the backdrop of an aging nation. The company generates revenue from Medicare/Medicaid government programs and insurance payments for medical rehabilitation.

The Pennant Group - PNTG Market Cap to Future Revenue Ratio (period 07/04/2022 - 11/16/2026)

The Pennant Group, Inc. - analytical breakdowns and key metrics (PNTG)

- stock price and consensus target price:
Fundamental company analysis:PNTG (The Pennant Group, Inc.)
Original product of The Pennant Group Corp

Forward P/S determines the market value of a business relative to expected sales volume, measuring the premium for potential growth. For The Pennant Group, Inc. (PNTG), this ratio reflects the monetization of ESG standard implementation and the optimization of bio-waste utilization in clinics. By analyzing the forward P/S, an investor can identify whether the asset is overbought or possesses hidden growth potential. The indicator's trend confirms fundamental stability and the quality of capital management.

Competitor analysis for The Pennant Group, Inc.

Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|DVA (DaVita Corp) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (surgerypartners.com) - Forward Price to Sales|Forward P/S Multiple PINC (Premier Inc)|National Vision - Price-to-Projected Revenue Ratio|PGNY - Price-to-Projected Revenue Ratio|ARDT - Forward P/S Multiple|SEM: Forward P/S Multiple|astranahealth.com (ASTH) - Forward P/S Multiple|MD (mednax.com) - Forward P/S Multiple|Forward P/S Multiple usph.com|Price-to-Projected Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Forward Price to Sales|Forward P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Market Cap to Future Revenue Ratio|EOLS - Price-to-Projected Revenue Ratio|Forward Price to Sales CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue MDWD|Price-to-Projected Revenue Ratio biote Corp.|Market Cap to Future Revenue Ratio thejoint.com JYNT|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple P3 Health PIII|Forward P/S Multiple GANX (Gain Therapeutics Inc.)|Forward P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - Forward P/S Multiple|CLGN: Price-to-Projected Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Concord Medical|AMS (American Shared Hospital Services Inc) - Forward P/S Multiple|MEDIROM Corp (MRM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ALBT|Market Cap to Expected Sales Ratio DIH Holding|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)